ARMATA PHARMACEUTICALS, INC. Sales Revenue, Services, Net (Deprecated 2018-01-31)
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Sales Revenue, Services, Net (Deprecated 2018-01-31) of $102.00 thousand for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueServicesNet · last filed 2015-05-15
- ARMATA PHARMACEUTICALS, INC. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2015-03-31 was $102.00K, a 1.92% decline year-over-year.
- ARMATA PHARMACEUTICALS, INC. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2014-12-31 was $101.00K.
- ARMATA PHARMACEUTICALS, INC. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2014-09-30 was $103.00K.
- ARMATA PHARMACEUTICALS, INC. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2014-06-30 was $101.00K, a 67.83% decline year-over-year.
- ARMATA PHARMACEUTICALS, INC. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2014 was $409.00K.
| Period end | Sales Revenue, Services, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Services, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 6 month as first filed | Sales Revenue, Services, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 9 month as first filed | Sales Revenue, Services, Net (Deprecated 2018-01-31) 12 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2015-03-31 | $102.00K 10-Q · filed 2015-05-15 | $203.00K derived: sum of 2 quarters · filed 2015-05-15 | $306.00K derived: sum of 3 quarters · filed 2015-05-15 | $407.00K derived: sum of 4 quarters · filed 2015-05-15 | ||||
| 2014-12-31 | $101.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-04-15 | $204.00K derived: sum of 2 quarters · filed 2015-04-15 | $305.00K derived: sum of 3 quarters · filed 2015-04-15 | $409.00K 10-K · filed 2015-04-15 | ||||
| 2014-09-30 | $103.00K 10-Q/A · filed 2015-04-15 | $0.00 10-Q · filed 2014-11-14 | $204.00K derived: sum of 2 quarters · filed 2015-04-15 | $308.00K 10-Q/A · filed 2015-04-15 | $310.00K 10-Q · filed 2014-11-14 | $56.00K derived: sum of 4 quarters · filed 2015-05-15 | ||
| 2014-06-30 | $101.00K 10-Q/A · filed 2015-04-15 | $310.00K 10-Q · filed 2014-09-12 | $205.00K 10-Q/A · filed 2015-04-15 | $310.00K 10-Q · filed 2014-09-12 | -$47.00K derived: sum of 3 quarters · filed 2015-05-15 | -$50.00K derived: sum of 4 quarters · filed 2015-05-15 | ||
| 2014-03-31 | $104.00K 10-Q · filed 2015-05-15 | $0.00 10-Q · filed 2014-05-20 | -$148.00K derived: sum of 2 quarters · filed 2015-05-15 | -$151.00K derived: sum of 3 quarters · filed 2015-05-15 | $163.00K derived: sum of 4 quarters · filed 2015-05-15 | |||
| 2013-12-31 | -$252.00K derived: 10-Q/A 12 month − 10-Q/A 9 month · filed 2015-04-15 | -$255.00K derived: sum of 2 quarters · filed 2015-04-15 | $59.00K derived: sum of 3 quarters · filed 2015-04-15 | $81.00K 10-Q/A · filed 2015-04-15 | $325.00K 10-Q · filed 2014-05-20 | |||
| 2013-09-30 | -$3.00K 10-Q/A · filed 2015-04-15 | $311.00K derived: sum of 2 quarters · filed 2015-04-15 | $333.00K 10-Q/A · filed 2015-04-15 | |||||
| 2013-06-30 | $314.00K 10-Q/A · filed 2015-04-15 | $336.00K 10-Q/A · filed 2015-04-15 | ||||||
| 2013-03-31 | $22.00K 10-Q/A · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |